Last Updated : September 20, 2006
Details
FilesGeneric Name:
Sunitinib malate
Project Status:
Complete
Therapeutic Area:
Cancer, Metastatic renal cell carcinoma
Manufacturer:
Pfizer Canada Inc.
Brand Name:
Sutent
Project Line:
Reimbursement Review
Project Number:
SR0077-000
Submission Type:
Resubmission
Indications:
Cancer, Metastatic renal cell carcinoma
Recommendation Type:
Do not list
Final Recommendation:
Files
Last Updated : September 20, 2006